49
Views
5
CrossRef citations to date
0
Altmetric
Review

Antibody therapy for Alzheimer’s disease

Pages 53-59 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mohammad Ali Faghihi, Salim Mottagui-Tabar & Claes Wahlestedt. (2004) Genetics of neurological disorders. Expert Review of Molecular Diagnostics 4:3, pages 317-332.
Read now

Articles from other publishers (4)

Fabrizio Bernini, Daniele Malferrari, Marcello Pignataro, Carlo Augusto Bortolotti, Giulia Di Rocco, Lidia Lancellotti, Maria Franca Brigatti, Rakez Kayed, Marco Borsari, Federica del Monte & Elena Castellini. (2016) Pre-amyloid oligomers budding:a metastatic mechanism of proteotoxicity. Scientific Reports 6:1.
Crossref
Claude P. Muller & Mike M. Putz. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
Xiaoning Bi, Michel Baudry, Jihua Liu, Yueqin Yao, Lawrence Fu, Fernando Brucher & Gary Lynch. (2004) Inhibition of Geranylgeranylation Mediates the Effects of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Inhibitors on Microglia. Journal of Biological Chemistry 279:46, pages 48238-48245.
Crossref
Michael A. Rogawski. (2014) What Is the Rationale for New Treatment Strategies in Alzheimer's Disease?. CNS Spectrums 9:S5, pages 6-12, 31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.